U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage
LB Pharmaceuticals Q2 net loss widens on higher R&D costs
Brief: Lb Pharmaceuticals Announces $150 Million Private Placement
LB Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: Lb Pharmaceuticals Initiates Pivotal Phase 3 Trial (Nova-2) For Lb-102 In Patients With Schizophrenia
Brief: Lb Pharmaceuticals Announces $100.0 Million Private Placement
Aktis Oncology files for US IPO as biotech listings rebound
Drug developer MapLight eyes $704.3 million valuation in US IPO (updated)
StubHub stretches post-IPO slide amid deal flurry